Formulation Development

Formulation Development

NextPharma PDS provides pre-formulation evaluation and formulation development services for oral solid, semi-solid, liquid and parenteral dosage forms of both small molecules and biologics.

Pre-formulation evaluation services include:

  • pKa determination
  • Partition coefficient
  • Chemical stability profile
  • Solubility determination
  • Crystal properties and polymorphism (DSC, XRPD)
  • Particle size, shape and surface area

Formulation Development Capabilities include:

DOSAGE FORM AVAILABLE FORMS CHARACTERISTIC OTHER FEATURES
Solid Dosage Tablets Uncoated tablets  
    Film coated tablets  
    Effervescent tablets  
  Capsules Hard capsules Granulation available
  Pellet Immediate release  
    Extended release  
    Gastric-resistant release  
  Powder Lyophilized sterile or
non-sterile
 
      Non-sterile
Semi-solid Dosage Ointments Non-sterile filled in tubes and single dose-units
  Creams Non-sterile filled in tubes and single dose-units
  Gels Non-sterile filled in tubes and single dose-units
Liquid Dosage Solutions Sterile or Non-sterile
(oral and topical)
Aqueous or solvent based
  Emulsions Sterile or Non-sterile
(oral and topical)
Aqueous or solvent based
  Suspensions Sterile or Non-sterile
(oral and topical)
Aqueous or solvent based


Process Validation

  • Manufacturing of development trial batches
  • Stability testing of trial batches
  • Selection of optimal formulation
  • Scale-up and from laboratory-scale to pilot scale and then to production scale batches
  • Manufacturing process validation
  • Technology transfer

We can offer the following specialist technologies:

  • Hormones (oral and topical)
  • Steroids (oral and topical)
  • Antibiotics (oral) including Penicillins and Cephalosporins
  • Lyophilization
  • Biologics (proteins, antibodies)
  • Controlled drugs